Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient
1. Tiziana reports strong immune effects from intranasal foralumab in Alzheimer's treatment. 2. Changes in immune cells linked to reduced inflammation shown via PET scans. 3. Foralumab may improve amyloid plaque clearance, opening new treatment avenues. 4. Tiziana demonstrates commitment to Alzheimer's therapies following promising study results. 5. The treatment was well-tolerated with no reported side effects.